D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
DFTX holding history
Definium Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DFTX overviewAll 13F holders of DFTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 315,410
- Value
- $14.8M
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 315,410 | $14.8M | <0.1% | +43,693+16.1% | Added | Holders |
| Q1 2026 | 271,717 | $5.14M | <0.1% | −22,005−7.5% | Reduced | Holders |
| Q4 2025 | 293,722 | $3.93M | <0.1% | +77,388+35.8% | Added | Holders |
| Q3 2025 | 216,334 | $2.55M | <0.1% | +157,570+268.1% | Added | Holders |
| Q2 2025 | 58,764 | $381.4K | <0.1% | −4,485−7.1% | Reduced | Holders |
| Q1 2025 | 63,249 | $370.0K | <0.1% | +63,249 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −183,029−100.0% | Sold out | Holders |
| Q1 2024 | 183,029 | $1.72M | <0.1% | +183,029 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −167,211−100.0% | Sold out | Holders |
| Q4 2021 | 167,211 | $231.0K | <0.1% | −3,311−1.9% | Reduced | Holders |
| Q3 2021 | 170,522 | $397.0K | <0.1% | +37,719+28.4% | Added | Holders |
| Q2 2021 | 132,803 | $458.0K | <0.1% | +132,803 | New | Holders |